From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves first drug for tardive dyskinesia

from Pharmacy Times

The FDA has approved valbenazine capsules, the first drug approved to treat adults with tardive dyskinesia. Tardive dyskinesia, a neurological condition, is characterized by repetitive involuntary movements, usually of the jaw, lips and tongue. Some individuals also experience involuntary movement of the extremities and difficulty breathing. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063